Bespoke Clinical Development Services for Biotechs

Karma Oncology provides flexible and specialized clinical development services tailored to the needs of small and emerging biotechs. With deep expertise across all phases of oncology drug development, Karma acts as an extension of clients' teams to advance their novel therapies from preclinical through commercialization. Karma's full-service capabilities span pre-clinical consulting, clinical trial execution and management, and pharmacovigilance and regulatory services. The company's adaptable, customized approach enables biotech sponsors to implement innovative clinical strategies, accelerate enrollment, leverage real-world data, and navigate regulatory requirements. Karma's knowledgeable, reliable, and accountable team has the experience and motivation to tackle any clinical development challenge.

With a collaborative, can-do attitude, Karma accelerates and derisks clinical development so biotech innovators can focus on their science and bring transformative new therapies to patients.